Brain differences in pain modulation in people with self-injury behaviour
Researchers at Karolinska Institutet in Sweden might have found an explanation for why people with self-injury behaviour generally feel less pain than others. The key seems to be a more effective pain-modulation system, a discovery that can benefit people seeking help for their self-harm. The findings are published in the journal Molecular Psychiatry.
Most people try to avoid pain, but some, especially adolescents and young adults, can sometimes subject themselves to physical injury. Self-harming is strongly associated with other mental health issues, such as anxiety and depression, but far from everyone with such a condition engages in self-injury.
“We have long tried to understand how people who display self-injury behaviour differ from others and why the pain itself isn’t a sufficient deterrent,” says Karin Jensen, researcher and group leader at the Department of Clinical Neuroscience, Karolinska Institutet, and the study’s corresponding author. “Previous studies how shown that people who self-harm are generally less sensitive to pain, but the mechanisms behind it are not fully understood.”
Tolerated more pain
In this present study, the researchers examined these mechanisms by comparing pain modulation in 41 women who had engaged in self-injury at least five times in the past year with 40 matched women without self-injury behaviour. The women, who were aged between 18 and 35, underwent laboratory pain tests at Karolinska University Hospital on two occasions in 2019-2020 during which they were asked to rate the pain they experienced from transient pressure and heat stimulations. Their brain activity during pain was also measured using MRI scans.
The researchers found that on average the self-harming women tolerated higher levels of pain than the controls. The brain scans also revealed differences in activation between the groups. Compared with the controls, the brain activity of the women with self-injury behaviour displayed more connections between brain areas directly involved in the perception of pain and those linked to the modulation of pain.
Another finding was that the difference in pain modulation was not determined by how long, how often or in what way the participants had engaged in self-injury.
Clinically useful knowledge
“Our study suggests that effective pain modulation is a risk factor for self-injury behaviour,” says Maria Lalouni, researcher at the Department of Clinical Neuroscience, Karolinska Institutet, and the study’s joint first author with Jens Fust, who recently earned his PhD on the project. “It also tells us more about differences in the brains of people who engage in self-injury, knowledge that can be used for improving the support provided to people seeking care for their behaviour as well as in conversations with patients to help them understand their self-injury and the need for treatment.”
Limitations to the study include the fact that women with self-injury behaviour tended to report more psychiatric comorbidities than the controls. They also took more drugs, such as antidepressants, which the researchers factored into their analysis.
The study was supported by grants from the Swedish Research Council and the Strategic Research Area Neuroscience (StratNeuro) at Karolinska Institutet, and by a donation from the Lundblad family to pain research.
Publication: “Augmented pain inhibition and higher integration of pain modulatory brain networks in women with self-injury behavior,” Maria Lalouni*, Jens Fust*, Johan Bjureberg, Gránit Kastrati, Robin Fondberg, Peter Fransson, Nitya Jayaram-Lindström, Eva Kosek, Clara Hellner, Karin B. Jensen, Molecular Psychiatry, online June 13, 2022, doi: 10.1038/s41380-022-01639-y
För mer information, kontakta:
Maria Lalouni, forskare
Institutionen för klinisk neurovetenskap
Tel: 070-947 3148
E-post: maria.lalouni@ki.se
Karin Jensen, forskare och gruppledare
Institutionen för klinisk neurovetenskap
Tel: 070-213 0811
E-post: karin.jensen@ki.se
Contact the Press Office and download photo: ki.se/pressroom
Karolinska Institutet is one of the world’s leading medical universities. Our vision is to advance knowledge about life and strive towards better health for all. Karolinska Institutet accounts for the single largest share of all academic medical research conducted in Sweden and offers the country’s broadest range of education in medicine and health sciences. The Nobel Assembly at Karolinska Institutet selects the Nobel laureates in Physiology or Medicine.
Tags:
